{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:47:10Z","timestamp":1793908030542,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-015-0169-z","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:14:28Z","timestamp":1452471268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-\u03b2\/periostin pathway in STZ-induced diabetic mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Han","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Hai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"issue":"5","key":"169_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jjcc.2013.09.013","volume":"63","author":"S Zhao","year":"2014","unstructured":"Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, et al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol. 2014;63(5):373\u20138.","journal-title":"J Cardiol"},{"issue":"4","key":"169_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCHEARTFAILURE.112.000123","volume":"6","author":"W Liu","year":"2013","unstructured":"Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L, Meng QJ, et al. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circ Heart Fail. 2013;6(4):833\u201344.","journal-title":"Circ Heart Fail"},{"issue":"10","key":"169_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.6061\/clinics\/2013(10)09","volume":"68","author":"MF Minicucci","year":"2013","unstructured":"Minicucci MF, dos Santos PP, Rafacho BP, Goncalves AF, Ardisson LP, Batista DF, et al. Periostin as a modulator of chronic cardiac remodeling after myocardial infarction. Clinics (Sao Paulo). 2013;68(10):1344\u20139.","journal-title":"Clinics (Sao Paulo)"},{"issue":"12","key":"169_CR4","doi-asserted-by":"publisher","first-page":"L1046","DOI":"10.1152\/ajplung.00139.2012","volume":"303","author":"PK Naik","year":"2012","unstructured":"Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012;303(12):L1046\u20131056.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"169_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.107.159517","volume":"102","author":"P Snider","year":"2008","unstructured":"Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res. 2008;102(7):752\u201360.","journal-title":"Circ Res"},{"issue":"6","key":"169_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.archoralbio.2014.03.003","volume":"59","author":"T Watanabe","year":"2014","unstructured":"Watanabe T, Yasue A, Tanaka E. Hypoxia-inducible factor-1alpha is required for transforming growth factor-beta1-induced type I collagen, periostin and alpha-smooth muscle actin expression in human periodontal ligament cells. Arch Oral Biol. 2014;59(6):595\u2013600.","journal-title":"Arch Oral Biol"},{"issue":"3","key":"169_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejps.2012.04.018","volume":"47","author":"V Soetikno","year":"2012","unstructured":"Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, et al. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Eur J Pharm Sci. 2012;47(3):604\u201314.","journal-title":"Eur. J. Pharm. Sci."},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1475-2840-11-73","volume":"11","author":"CJ Li","year":"2012","unstructured":"Li CJ, Lv L, Li H, Yu DM. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol. 2012;11:73.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"169_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.numecd.2010.07.004","volume":"20","author":"A Borriello","year":"2010","unstructured":"Borriello A, Cucciolla V, Della Ragione F, Galletti P. Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis. 2010;20(8):618\u201325.","journal-title":"Nutr. Metab. Cardiovasc. Dis"},{"issue":"14","key":"169_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/CIRCULATIONAHA.111.067801","volume":"125","author":"F Qin","year":"2012","unstructured":"Qin F, Siwik DA, Luptak I, Hou X, Wang L, Higuchi A, et al. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation. 2012;125(14):1757\u201364. S1751-1756.","journal-title":"Circulation"},{"key":"169_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1475-2840-11-99","volume":"11","author":"PH Huang","year":"2012","unstructured":"Huang PH, Chen JW, Lin CP, Chen YH, Wang CH, Leu HB, et al. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions. Cardiovasc Diabetol. 2012;11:99.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"169_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072120","volume":"8","author":"J Bai","year":"2013","unstructured":"Bai J, Zhang N, Hua Y, Wang B, Ling L, Ferro A, et al. Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. PLoS One. 2013;8(9), e72120.","journal-title":"PLoS One"},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2840-13-35","volume":"13","author":"RH Du","year":"2014","unstructured":"Du RH, Dai T, Cao WJ, Lu M, Ding JH, Hu G. Kir6.2-containing ATP-sensitive K(+) channel is required for cardioprotection of resveratrol in mice. Cardiovascular diabetology. 2014;13:35.","journal-title":"Cardiovascular diabetology"},{"issue":"5","key":"169_CR14","doi-asserted-by":"publisher","first-page":"H2078","DOI":"10.1152\/ajpheart.01363.2007","volume":"294","author":"K Venkatachalam","year":"2008","unstructured":"Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B. Resveratrol inhibits high glucose-induced PI3K\/Akt\/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2008;294(5):H2078\u20132087.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"169_CR15","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jacc.2009.11.066","volume":"55","author":"T Tang","year":"2010","unstructured":"Tang T, Lai NC, Hammond HK, Roth DM, Yang Y, Guo T, et al. Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice. J Am Coll Cardiol. 2010;55(14):1476\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"169_CR16","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.athoracsur.2009.07.038","volume":"88","author":"WE Stansfield","year":"2009","unstructured":"Stansfield WE, Andersen NM, Tang RH, Selzman CH. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg. 2009;88(6):1916\u201321.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"169_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.20071297","volume":"205","author":"M Shimazaki","year":"2008","unstructured":"Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med. 2008;205(2):295\u2013303.","journal-title":"J Exp Med"},{"issue":"7","key":"169_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00018-013-1494-y","volume":"71","author":"SJ Conway","year":"2014","unstructured":"Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014;71(7):1279\u201388.","journal-title":"Cell. Mol. Life Sci"},{"issue":"27","key":"169_CR19","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1073\/pnas.1204708109","volume":"109","author":"A Lorts","year":"2012","unstructured":"Lorts A, Schwanekamp JA, Baudino TA, McNally EM, Molkentin JD. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proc Natl Acad Sci U S A. 2012;109(27):10978\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"169_CR20","first-page":"247","volume":"62","author":"P Zou","year":"2010","unstructured":"Zou P, Wu LL, Wu D, Fan D, Cui XB, Zhou Y, et al. [High glucose increases periostin expression and the related signal pathway in adult rat cardiac fibroblasts]. Sheng li xue bao. 2010;62(3):247\u201354.","journal-title":"Sheng li xue bao"},{"issue":"2","key":"169_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","volume":"74","author":"A Leask","year":"2007","unstructured":"Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res. 2007;74(2):207\u201312.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"169_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/JME-12-0194","volume":"50","author":"SE Song","year":"2013","unstructured":"Song SE, Kim YW, Kim JY, Lee DH, Kim JR, Park SY. IGFBP5 mediates high glucose-induced cardiac fibroblast activation. J Mol Endocrinol. 2013;50(3):291\u2013303.","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"169_CR23","doi-asserted-by":"publisher","first-page":"H1131","DOI":"10.1152\/ajpheart.00763.2004","volume":"288","author":"ER Olson","year":"2005","unstructured":"Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol. 2005;288(3):H1131\u20131138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"169_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/01902148.2010.524722","volume":"37","author":"E Fagone","year":"2011","unstructured":"Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, Lo Furno D, et al. Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK\/Akt inhibition and PTEN restoration. Exp Lung Res. 2011;37(3):162\u201374.","journal-title":"Exp Lung Res"},{"key":"169_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbi.2014.12.031","volume":"227","author":"J Liu","year":"2015","unstructured":"Liu J, Zhuo X, Liu W, Wan Z, Liang X, Gao S, et al. Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-beta1-Smad3 signaling pathway. Chem Biol Interact. 2015;227:45\u201352.","journal-title":"Chem Biol Interact"},{"issue":"5","key":"169_CR26","doi-asserted-by":"publisher","first-page":"H424","DOI":"10.1152\/ajpheart.00454.2014","volume":"308","author":"T Chen","year":"2015","unstructured":"Chen T, Li J, Liu J, Li N, Wang S, Liu H, et al. Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-beta\/Smad3 pathway. Am J Physiol Heart Circ Physiol. 2015;308(5):H424\u2013434.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"169_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","volume":"40","author":"MO Gray","year":"1998","unstructured":"Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res. 1998;40(2):352\u201363.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"169_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cvr\/cvr067","volume":"91","author":"L Li","year":"2011","unstructured":"Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, et al. Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res. 2011;91(1):80\u20139.","journal-title":"Cardiovasc Res"},{"issue":"16","key":"169_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.yexcr.2012.06.015","volume":"318","author":"J Gu","year":"2012","unstructured":"Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF, et al. Angiotensin II increases CTGF expression via MAPKs\/TGF-beta1\/TRAF6 pathway in atrial fibroblasts. Exp Cell Res. 2012;318(16):2105\u201315.","journal-title":"Exp Cell Res"},{"issue":"1","key":"169_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2013.06.046","volume":"169","author":"CF Tsai","year":"2013","unstructured":"Tsai CF, Yang SF, Chu HJ, Ueng KC. Cross-talk between mineralocorticoid receptor\/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. Int J Cardiol. 2013;169(1):17\u201328.","journal-title":"Int J Cardiol"},{"issue":"4","key":"169_CR31","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ajpath.2011.06.002","volume":"179","author":"K Sen","year":"2011","unstructured":"Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179(4):1756\u201367.","journal-title":"Am J Pathol"},{"issue":"3","key":"169_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/cvr\/cvs275","volume":"96","author":"YA Chiao","year":"2012","unstructured":"Chiao YA, Ramirez TA, Zamilpa R, Okoronkwo SM, Dai Q, Zhang J, et al. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice. Cardiovasc Res. 2012;96(3):444\u201355.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"169_CR33","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2013060664","volume":"25","author":"M Mael-Ainin","year":"2014","unstructured":"Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014;25(8):1724\u201336.","journal-title":"J. Am. Soc. Nephrol"},{"issue":"2","key":"169_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm1536","volume":"13","author":"RD Cohn","year":"2007","unstructured":"Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, et al. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med. 2007;13(2):204\u201310.","journal-title":"Nat Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-015-0169-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T22:52:19Z","timestamp":1506120739000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-015-0169-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1186\/s12872-015-0169-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]},"article-number":"5"}}